VALIANT LABORATORIES
|
The Current P/E Ratio of VALIANT LABORATORIES is 69.03.
| Share Price | ₹64.5 | Jan 14,2026 |
| Market Cap | ₹350.0 Cr | |
| Earnings-TTM | ₹5.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 69.03x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of VALIANT LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹350.0 Cr] as on Jan 14,2026
(/) Earnings [ ₹5.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 69.03x ]
Thus, for VALIANT LABORATORIES , the investors are currently willing to pay 69.03 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VALIANT LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VALIANT LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VALIANT LABORATORIES
PE Ratio Performance Analysis for VALIANT LABORATORIES
- VALIANT LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 612.41x.
- VALIANT LABORATORIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, VALIANT LABORATORIES 's p/e ratio peaked in Mar2024 at 1837.23x.
- VALIANT LABORATORIES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does VALIANT LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| VALIANT LABORATORIES | 5.07 | 69.03 | 350.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 38.79 | 408,019.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 67.91 | 168,752.0 |
| CIPLA LTD | 5,453.86 | 21.25 | 115,883.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 63.34 | 135,542.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.31 | 99,024.7 |
| MANKIND PHARMA LTD | 1,767.06 | 52.42 | 92,629.3 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 17.89 | 88,951.1 |
| LUPIN LTD | 4,347.53 | 23.06 | 100,267.0 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.88 | 68,549.1 |
| ABBOTT INDIA LTD | 1,508.95 | 39.29 | 59,284.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VALIANT LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.31x |
| Max industry PE | 69.03x |
| Median industry PE | 38.79x |
| Average industry PE | 39.11x |
You may also like the below Video Courses